[1]刘正兵综述,宫剑滨审校.橙皮苷及橙皮素对心血管系统保护作用及机制的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2017,19(05):504-507.[doi:10.3969/j.issn.1672-271X.2017.05.014]

点击复制

橙皮苷及橙皮素对心血管系统保护作用及机制的研究进展()

分享到62.8K

参考文献/References:

[1]Cho J. Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin[J]. Arch Pharm Res, 2006, 29(8):699-706.
[2］田美杰, 孙英健, 官佳懿, 等. 橙皮苷对小鼠抗氧化作用及抗氧化酶基因表达的影响[J]. 中国实验动物学报, 2016, 24(2): 150-157.
[3］Oguzturk H, Ciftci O, Cetin A, et al. Beneficial effects of hesperidin following cis-diamminedichloroplatinum-induced damage in heart of rats [J]. Niger J Clin Pract, 2016, 19(1): 99-103.
[4］Jain M, Parmar HS. Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation [J]. Inflamm Res, 2011, 60(5): 483-491.
[5］Leray V, Freuchet B, Le Bloc’h J, et al. Effect of citruspolyphenol-and curcumin-supplemented diet on inflammatory state in obese cats [J]. Br J Nutr, 2011, 106 (Suppl 1): 198-201.
[6］Bentli R, Ciftci O, Cetin A, et al. Oral administration of hesperidin, a citrus flavonone, in rats counteracts the oxidative stress, the inflammatory cytokine production, and the hepatotoxicity induced by the ingestion of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)[J]. Eur Cytokine Netw, 2013, 24(2): 91-96.
[7］Haidari F, Heybar H, Jalali MT, et al. Hesperidin supplementation modulates inflammatory responses following myocardial infarction[J]. J Am Coll Nutr, 2015, 34(3): 205-211.
[8］Li X, Hu X, Wang J, et al. Short-term hesperidin pretreatment attenuates rat myocardial ischemia/reperfusion injury by inhibiting high mobility group box 1 protein expression via the PI3K/Akt Pathway[J]. Cell Physiol Biochem, 2016, 39(5):1850-1862.
[9］Siddesha JM, Valente AJ, Sakamuri SS, et al. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK[J]. J Mol Cell Cardiol, 2013, 65:9-18.
[10]Deng W, Jiang D, Fang Y, et al. Hesperetin protects against cardiac remodelling induced by pressure overload in mice [J]. J Mol Histol, 2013, 44(5):575-585.
[11]邓伟, 刘源, 陈昌贵, 等. 橙皮素对脂多糖诱导H9C2心肌细胞活性氧水平的影响[J]. 医学研究杂志, 2014, 43(11): 36-38.
[12]刘源, 唐其柱, 李利娜, 等. 橙皮素对血管紧张素II诱导的心肌成纤维细胞增殖及胶原蛋白合成的抑制作用[J]. 中华医学杂志, 2014, 94(36): 2852-2856.
[13]张凯, 胡文星, 赵守城, 等. 依折麦布联合舒洛地特对高龄冠心病和糖尿病患者调脂、抗炎作用的临床观察[J]. 东南国防医药, 2012, 14(5): 428-431.
[14]邓超, 祝孝勇, 姜醒华. 成纤维细胞生长因子21在心血管疾病中的保护作用[J]. 医学研究生学报, 2017, 30(6): 661-664.
[15]李雄英, 陈素红, 吕圭源, 等. 橙皮苷对脂肪乳剂致高脂血症模型大鼠血脂及血液流变学的影响[J]. 浙江中医药大学学报, 2013, 37(3): 308-312.
[16]陆红玲, 钱民章. 橙皮苷对辛伐他汀调脂作用及细胞色素P4503A mRNA表达的影响[J]. 中国药理学通报, 2004, 20(3): 330-334.
[17]Kim HJ, Jeon SM, Lee MK, et al. Comparison of hesperetin and its metabolites for cholesterol-lowering and antioxidative efficacy in hypercholesterolemic hamsters [J]. J Med Food, 2010, 13(4): 808-814.
[18]朱小琴, 华晓芳, 李磊, 等. 橙皮素抗apoE-/-小鼠动脉粥样硬化作用及其机制[J]. 疑难病杂志, 2014, 14(2): 171-174.
[19]Iio A, Ohguchi K, Iinuma M, et al. Hesperetin upregulates ABCA1 expression and promotes cholesterol efflux from THP-1 macrophages [J]. J Nat Prod, 2012, 75(4):563-566.
[20]Selvaraj P, Pugalendi KV. Hesperidin, a flavanone glycoside, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats [J]. Redox ReP, 2010, 15(5): 217-223.
[21]Agrawal YO, Sharma PK, Shrivastava B, et al. Hesperidin blunts streptozotocin-isoproternol induced myocardial toxicity in rats by altering of PPAR-γ receptor [J]. Chem Biol Interact, 2014, 219: 211-220.
[22]Yogeeta SK, Hanumantra RB, Gnanapragasam A, et al.Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid [J]. Basic Clin Pharmacol Toxicol, 2006, 98(5):467-472.
[23]李雪飞, 江洪, 胡笑容, 等. 橙皮苷对大鼠心肌缺血/再灌注损伤诱导自噬的影响机制研究[J]. 疑难病杂志, 2015, 14(10): 1070-1073.
[24]Roohbakhsh A, Parhiz H, Soltani F, et al. Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases [J]. Life Sci, 2015, 124: 64-74.
[25]张冬松, 高慧媛, 吴立军. 橙皮苷药理活性研究进展[J]. 中国现代中药, 2006, 8(7): 25-26.
[26]Jin YR, Han XH, Zhang YH, et al. Antiplatelet activity of hesperetin,a bioflavonoid,is mainly mediated by inhibition of PLC-gamma 2 phosphorylation and cyclooxygenase-1 activity [J]. Atherosclerosis, 2007, 194(1): 144-152.
[27]Whitman SC, Kurowska EM, Manthey JA, et al. Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages [J]. Atherosclerosis, 2005, 178(1): 25-32.
[28]Yu HY, Park SW, Chung IM, et al. Anti-platelet effects of yuzu extract and its component [J]. Food Chem Toxicol, 2011, 49(12): 3018-3024.
[29]Chiou CS, Lin JW, Kao PF, et al. Effects of hesperidin on cyclic strain-induced endothelin-1 release in human umbilical vein endothelial cells [J]. Clin Exp Pharmacol Physiol, 2008, 35(8): 938-943.
[30]Yamamoto M, Suzuki A, Jokura H, et al. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats [J]. Nutrition, 2008, 24(5): 470-476.
[31]Galati EM, Trovato A, Kirjavainen S, et al. Biological Effects of Hesperidin, A Citrus Flavonoid. 3. Antihypertensive And DiureticActivityin Rat [J]. J Farm, 1996, 51(3): 219-221.
[32]Salden BN, Troost FJ, de Groot E, et al.Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals [J]. Am J Clin Nutr, 2016,104(6):1523-1533.
[33]王巍, 杨智昉, 王红卫, 等.橙皮苷对糖尿病大鼠心泵功能和心率变异性的影响[J]. 内科理论与实践, 2011, 6(4): 291-294.
[34]Gandhi C, Upaganalawar A, Balaraman R. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin [J]. Free Radic Res，2009,43(9): 817-827.

相似文献/References: